A certain proportion of high-risk supratentorial ependymomas, including a fraction of ST-EPN-RELA including the EP1NS cells, are known to harbour homozygous deletions of CDKN2A (Milde et al., 2011; Pajtler et al., 2015). The gene discussed is CDKN2A; the disease is ependymoma.